Seeking Alpha

Shane Skinner's  Instablog

Shane Skinner
Send Message
Shane Skinner has invested in biotech companies for almost 20 years and placed over $2.6 million in biotech stock trades in 2013. He has held various financial leadership positions over the past 17 years throughout the United States and Europe including Chief Financial Officer. Shane graduated... More
My blog:
  • Cyclacel Reported Earnings After The Market Closed With An Update On Phase 3 Enrollment In AML 0 comments
    Mar 25, 2014 4:39 PM | about stocks: CYCC

    Cyclacel (NASDAQ:CYCC) reported earnings after the market closed today and provided an updated on enrollment for it's phase 3 trial of it's lead compound to treat AML in elderly patients. They have expanded into approximately 80 sites which brings total enrolling sites to approximately 120 after you included the 40 sites in the United States. They have now enrolled 60% of patients in the trial and expect to complete enrollment by the end of the year with top line results in 2015. They have an agreed upon Special Protocol Assessment with the FDA for this trial. They are also evaluating the opportunity to begin a second phase 3 trial for the same compound to treat MDS and expect to provide an update on this opportunity later this year.

    I own a small position of 2,000 shares in Cyclacel. The company has a small market cap of $68 million with a phase 3 trial expecting results in 2015 in an indication (AML) which needs improved treatment options so I believe the stock is a good value.

    Disclosure: I am long CYCC.

    Themes: Biotech Stocks: CYCC
Back To Shane Skinner's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.